219 related articles for article (PubMed ID: 35835913)
1. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.
Banday AR; Stanifer ML; Florez-Vargas O; Onabajo OO; Papenberg BW; Zahoor MA; Mirabello L; Ring TJ; Lee CH; Albert PS; Andreakos E; Arons E; Barsh G; Biesecker LG; Boyle DL; Brahier MS; Burnett-Hartman A; Carrington M; Chang E; Choe PG; Chisholm RL; Colli LM; Dalgard CL; Dude CM; Edberg J; Erdmann N; Feigelson HS; Fonseca BA; Firestein GS; Gehring AJ; Guo C; Ho M; Holland S; Hutchinson AA; Im H; Irby L; Ison MG; Joseph NT; Kim HB; Kreitman RJ; Korf BR; Lipkin SM; Mahgoub SM; Mohammed I; Paschoalini GL; Pacheco JA; Peluso MJ; Rader DJ; Redden DT; Ritchie MD; Rosenblum B; Ross ME; Anna HPS; Savage SA; Sharma S; Siouti E; Smith AK; Triantafyllia V; Vargas JM; Vargas JD; Verma A; Vij V; Wesemann DR; Yeager M; Yu X; Zhang Y; Boulant S; Chanock SJ; Feld JJ; Prokunina-Olsson L
Nat Genet; 2022 Aug; 54(8):1103-1116. PubMed ID: 35835913
[TBL] [Abstract][Full Text] [Related]
2. Genetic regulation of
Banday AR; Stanifer ML; Florez-Vargas O; Onabajo OO; Zahoor MA; Papenberg BW; Ring TJ; Lee CH; Andreakos E; Arons E; Barsh G; Biesecker LG; Boyle DL; Burnett-Hartman A; Carrington M; Chang E; Choe PG; Chrisholm RL; Dalgard C; Edberg J; Erdmann N; Feigelson HS; Firestein GS; Gehring AJ; Ho M; Holland S; Hutchinson AA; Im H; Ison MG; Kim HB; Kreitman RJ; Korf BR; Mirabello L; Pacheco JA; Peluso MJ; Rader DJ; Redden DT; Ritchie MD; Rosenbloom B; Sant Anna HP; Savage S; Siouti E; Triantafyllia V; Vargas JM; Verma A; Vij V; Wesemann DR; Yeager M; Yu X; Zhang Y; Boulant S; Chanock SJ; Feld JJ; Prokunina-Olsson L
medRxiv; 2021 Jul; ():. PubMed ID: 34282422
[TBL] [Abstract][Full Text] [Related]
3. A prenylated dsRNA sensor protects against severe COVID-19.
Wickenhagen A; Sugrue E; Lytras S; Kuchi S; Noerenberg M; Turnbull ML; Loney C; Herder V; Allan J; Jarmson I; Cameron-Ruiz N; Varjak M; Pinto RM; Lee JY; Iselin L; Palmalux N; Stewart DG; Swingler S; Greenwood EJD; Crozier TWM; Gu Q; Davies EL; Clohisey S; Wang B; Trindade Maranhão Costa F; Freire Santana M; de Lima Ferreira LC; Murphy L; Fawkes A; Meynert A; Grimes G; ; Da Silva Filho JL; Marti M; Hughes J; Stanton RJ; Wang ECY; Ho A; Davis I; Jarrett RF; Castello A; Robertson DL; Semple MG; Openshaw PJM; Palmarini M; Lehner PJ; Baillie JK; Rihn SJ; Wilson SJ
Science; 2021 Oct; 374(6567):eabj3624. PubMed ID: 34581622
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection.
Yousfi FZE; Haroun AE; Nebhani C; Belayachi J; Askander O; Fahime EE; Fares H; Ennibi K; Abouqal R; Razine R; Bouhouche A
Arch Virol; 2024 Apr; 169(5):109. PubMed ID: 38658463
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide variants in the
Chávez-Vélez E; Álvarez-Nava F; Torres-Vinueza A; Balarezo-Díaz T; Pilataxi K; Acosta-López C; Peña IZ; Narváez K
Front Cell Infect Microbiol; 2024; 14():1322882. PubMed ID: 38694517
[TBL] [Abstract][Full Text] [Related]
6. Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort.
Skerenova M; Cibulka M; Dankova Z; Holubekova V; Kolkova Z; Lucansky V; Dvorska D; Kapinova A; Krivosova M; Petras M; Baranovicova E; Baranova I; Novakova E; Liptak P; Banovcin P; Bobcakova A; Rosolanka R; Janickova M; Stanclova A; Gaspar L; Caprnda M; Prosecky R; Labudova M; Gabbasov Z; Rodrigo L; Kruzliak P; Lasabova Z; Matakova T; Halasova E
Adv Med Sci; 2024 Mar; 69(1):198-207. PubMed ID: 38555007
[TBL] [Abstract][Full Text] [Related]
7. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
Magusali N; Graham AC; Piers TM; Panichnantakul P; Yaman U; Shoai M; Reynolds RH; Botia JA; Brookes KJ; Guetta-Baranes T; Bellou E; Bayram S; Sokolova D; Ryten M; Sala Frigerio C; Escott-Price V; Morgan K; Pocock JM; Hardy J; Salih DA
Brain; 2021 Dec; 144(12):3727-3741. PubMed ID: 34619763
[TBL] [Abstract][Full Text] [Related]
8. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19.
Huffman JE; Butler-Laporte G; Khan A; Pairo-Castineira E; Drivas TG; Peloso GM; Nakanishi T; ; Ganna A; Verma A; Baillie JK; Kiryluk K; Richards JB; Zeberg H
Nat Genet; 2022 Feb; 54(2):125-127. PubMed ID: 35027740
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.
Kjær KH; Pahus J; Hansen MF; Poulsen JB; Christensen EI; Justesen J; Martensen PM
BMC Cell Biol; 2014 Sep; 15():33. PubMed ID: 25205466
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.
Li H; Reksten TR; Ice JA; Kelly JA; Adrianto I; Rasmussen A; Wang S; He B; Grundahl KM; Glenn SB; Miceli-Richard C; Bowman S; Lester S; Eriksson P; Eloranta ML; Brun JG; Gøransson LG; Harboe E; Guthridge JM; Kaufman KM; Kvarnström M; Cunninghame Graham DS; Patel K; Adler AJ; Farris AD; Brennan MT; Chodosh J; Gopalakrishnan R; Weisman MH; Venuturupalli S; Wallace DJ; Hefner KS; Houston GD; Huang AJW; Hughes PJ; Lewis DM; Radfar L; Vista ES; Edgar CE; Rohrer MD; Stone DU; Vyse TJ; Harley JB; Gaffney PM; James JA; Turner S; Alevizos I; Anaya JM; Rhodus NL; Segal BM; Montgomery CG; Scofield RH; Kovats S; Mariette X; Rönnblom L; Witte T; Rischmueller M; Wahren-Herlenius M; Omdal R; Jonsson R; Ng WF; ; Nordmark G; Lessard CJ; Sivils KL
PLoS Genet; 2017 Jun; 13(6):e1006820. PubMed ID: 28640813
[TBL] [Abstract][Full Text] [Related]
11. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.
Zhou S; Butler-Laporte G; Nakanishi T; Morrison DR; Afilalo J; Afilalo M; Laurent L; Pietzner M; Kerrison N; Zhao K; Brunet-Ratnasingham E; Henry D; Kimchi N; Afrasiabi Z; Rezk N; Bouab M; Petitjean L; Guzman C; Xue X; Tselios C; Vulesevic B; Adeleye O; Abdullah T; Almamlouk N; Chen Y; Chassé M; Durand M; Paterson C; Normark J; Frithiof R; Lipcsey M; Hultström M; Greenwood CMT; Zeberg H; Langenberg C; Thysell E; Pollak M; Mooser V; Forgetta V; Kaufmann DE; Richards JB
Nat Med; 2021 Apr; 27(4):659-667. PubMed ID: 33633408
[TBL] [Abstract][Full Text] [Related]
12. Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor.
Danziger O; Patel RS; DeGrace EJ; Rosen MR; Rosenberg BR
PLoS Pathog; 2022 Apr; 18(4):e1010464. PubMed ID: 35421191
[TBL] [Abstract][Full Text] [Related]
13. OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages.
Lee WB; Choi WY; Lee DH; Shim H; Kim-Ha J; Kim YJ
BMB Rep; 2019 Feb; 52(2):133-138. PubMed ID: 30078389
[TBL] [Abstract][Full Text] [Related]
14. Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication.
Lytras S; Wickenhagen A; Sugrue E; Stewart DG; Swingler S; Sims A; Jackson Ireland H; Davies EL; Ludlam EM; Li Z; Hughes J; Wilson SJ
PLoS Biol; 2023 Nov; 21(11):e3002398. PubMed ID: 38015855
[TBL] [Abstract][Full Text] [Related]
15. 2'-5'-Oligoadenylate synthetase 1 polymorphisms are associated with tuberculosis: a case-control study.
Wu S; Wang Y; Chen G; Zhang M; Wang M; He JQ
BMC Pulm Med; 2018 Nov; 18(1):180. PubMed ID: 30497421
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection.
Alagarasu K; Honap T; Damle IM; Mulay AP; Shah PS; Cecilia D
Infect Genet Evol; 2013 Mar; 14():390-5. PubMed ID: 23337612
[TBL] [Abstract][Full Text] [Related]
17. Structure of the 5' untranslated region in SARS-CoV-2 genome and its specific recognition by innate immune system
Bignon E; Miclot T; Terenzi A; Barone G; Monari A
Chem Commun (Camb); 2022 Feb; 58(13):2176-2179. PubMed ID: 35060977
[TBL] [Abstract][Full Text] [Related]
18. Endomembrane targeting of human OAS1 p46 augments antiviral activity.
Soveg FW; Schwerk J; Gokhale NS; Cerosaletti K; Smith JR; Pairo-Castineira E; Kell AM; Forero A; Zaver SA; Esser-Nobis K; Roby JA; Hsiang TY; Ozarkar S; Clingan JM; McAnarney ET; Stone AE; Malhotra U; Speake C; Perez J; Balu C; Allenspach EJ; Hyde JL; Menachery VD; Sarkar SN; Woodward JJ; Stetson DB; Baillie JK; Buckner JH; Gale M; Savan R
Elife; 2021 Aug; 10():. PubMed ID: 34342578
[TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
Tessier MC; Qu HQ; Fréchette R; Bacot F; Grabs R; Taback SP; Lawson ML; Kirsch SE; Hudson TJ; Polychronakos C
J Med Genet; 2006 Feb; 43(2):129-32. PubMed ID: 16014697
[TBL] [Abstract][Full Text] [Related]
20. 2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer.
Mandal S; Abebe F; Chaudhary J
Cancer; 2011 Dec; 117(24):5509-18. PubMed ID: 21638280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
